Skip to main content
Erschienen in: Journal of Neurology 10/2012

01.10.2012 | Original Communication

Can we overcome the ‘clinico-radiological paradox’ in multiple sclerosis?

verfasst von: Kerstin Hackmack, Martin Weygandt, Jens Wuerfel, Caspar F. Pfueller, Judith Bellmann-Strobl, Friedemann Paul, John-Dylan Haynes

Erschienen in: Journal of Neurology | Ausgabe 10/2012

Einloggen, um Zugang zu erhalten

Abstract

The association between common neuroradiological markers of multiple sclerosis (MS) and clinical disability is weak, a phenomenon known as the clinico-radiological paradox. Here, we investigated to which degree it is possible to predict individual disease profiles from conventional magnetic resonance imaging (MRI) using multivariate analysis algorithms. Specifically, we conducted cross-validated canonical correlation analyses to investigate the predictive information contained in conventional MRI data of 40 MS patients for the following clinical parameters: disease duration, motor disability (9-Hole Peg Test, Timed 25-Foot Walk Test), cognitive dysfunction (Paced Auditory Serial Addition Test), and the expanded disability status scale (EDSS). It turned out that the information in the spatial patterning of MRI data predicted the clinical scores with correlations of up to 0.80 (p < 10−9). Maximal predictive information for disease duration was identified in the precuneus and somatosensory cortex. Areas in the precuneus and precentral gyrus were maximally informative for motor disability. Cognitive dysfunction could best be predicted using data from the angular gyrus and superior parietal lobe. For EDSS, the inferior frontal gyrus was maximally informative. In conclusion, conventional MRI is highly predictive of clinical disability in MS when pattern-based algorithms are used for prediction. Thus, the so-called clinico-radiological paradox is not apparent when using suitable analysis techniques.
Literatur
1.
Zurück zum Zitat McDonald WI, Compston A, Edan G et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 50:121–127PubMedCrossRef McDonald WI, Compston A, Edan G et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 50:121–127PubMedCrossRef
2.
Zurück zum Zitat Bakshi R, Thompson AJ, Rocca MA et al (2008) MRI in multiple sclerosis: current status and future prospects. Lancet Neurol 7:615–625PubMedCrossRef Bakshi R, Thompson AJ, Rocca MA et al (2008) MRI in multiple sclerosis: current status and future prospects. Lancet Neurol 7:615–625PubMedCrossRef
3.
Zurück zum Zitat Barkhof F (1999) MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS). Mult Scler 5:283–286PubMed Barkhof F (1999) MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS). Mult Scler 5:283–286PubMed
4.
Zurück zum Zitat Barkhof F (2002) The clinico-radiological paradox in multiple sclerosis revisited [Review]. Curr Opin Neurol 15:239–245PubMedCrossRef Barkhof F (2002) The clinico-radiological paradox in multiple sclerosis revisited [Review]. Curr Opin Neurol 15:239–245PubMedCrossRef
5.
Zurück zum Zitat Filippi M, Grossman RI (2002) MRI techniques to monitor MS evolution: the present and the future. Neurology 58:1147–1153PubMedCrossRef Filippi M, Grossman RI (2002) MRI techniques to monitor MS evolution: the present and the future. Neurology 58:1147–1153PubMedCrossRef
6.
Zurück zum Zitat Filippi M, Rocca MA (2005) MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system. J Neurol 252(Suppl):16–24CrossRef Filippi M, Rocca MA (2005) MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system. J Neurol 252(Suppl):16–24CrossRef
7.
Zurück zum Zitat Klöppel S, Chu C, Tan GC et al (2009) Automatic detection of preclinical neurodegeneration: presymptomatic Huntington disease. Neurology 72:426–431PubMedCrossRef Klöppel S, Chu C, Tan GC et al (2009) Automatic detection of preclinical neurodegeneration: presymptomatic Huntington disease. Neurology 72:426–431PubMedCrossRef
8.
Zurück zum Zitat Klöppel S, Stonnington CM, Chu C et al (2008) Automatic classification of MR scans in Alzheimer’s disease. Brain 131:681–689PubMedCrossRef Klöppel S, Stonnington CM, Chu C et al (2008) Automatic classification of MR scans in Alzheimer’s disease. Brain 131:681–689PubMedCrossRef
9.
Zurück zum Zitat Stonnington CM, Chu C, Klöppel S et al (2010) Predicting clinical scores from magnetic resonance scans in Alzheimer’s disease. Neuroimage 51:1405–1413PubMedCrossRef Stonnington CM, Chu C, Klöppel S et al (2010) Predicting clinical scores from magnetic resonance scans in Alzheimer’s disease. Neuroimage 51:1405–1413PubMedCrossRef
10.
Zurück zum Zitat Wang Y, Fan Y, Bhatt P, Davatzikos C (2010) High-dimensional pattern regression using machine learning: from medical images to continuous clinical variables. Neuroimage 50:1519–1535PubMedCrossRef Wang Y, Fan Y, Bhatt P, Davatzikos C (2010) High-dimensional pattern regression using machine learning: from medical images to continuous clinical variables. Neuroimage 50:1519–1535PubMedCrossRef
11.
Zurück zum Zitat Cutter GR, Baier ML, Rudick RA et al (1999) Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 122:871–882PubMedCrossRef Cutter GR, Baier ML, Rudick RA et al (1999) Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 122:871–882PubMedCrossRef
12.
Zurück zum Zitat Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452PubMedCrossRef Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452PubMedCrossRef
13.
Zurück zum Zitat Weygandt M, Hackmack K, Pfueller C et al (2011) MRI pattern recognition in multiple sclerosis normal-appearing brain areas. PLoS One 6:e21138PubMedCrossRef Weygandt M, Hackmack K, Pfueller C et al (2011) MRI pattern recognition in multiple sclerosis normal-appearing brain areas. PLoS One 6:e21138PubMedCrossRef
14.
Zurück zum Zitat Paul F, Waiczies S, Wuerfel J et al (2008) Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis. PLoS One 3:e1928PubMedCrossRef Paul F, Waiczies S, Wuerfel J et al (2008) Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis. PLoS One 3:e1928PubMedCrossRef
15.
Zurück zum Zitat Wuerfel J, Bellmann-Strobl J, Brunecker P et al (2004) Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. Brain 127:111–119PubMedCrossRef Wuerfel J, Bellmann-Strobl J, Brunecker P et al (2004) Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. Brain 127:111–119PubMedCrossRef
17.
Zurück zum Zitat Weygandt M, Schaefer A, Schienle A, Haynes JD (2011) Diagnosing different binge-eating disorders based on reward-related brain activation patterns. Hum Brain Mapp. doi:10.1002/hbm.21345 PubMed Weygandt M, Schaefer A, Schienle A, Haynes JD (2011) Diagnosing different binge-eating disorders based on reward-related brain activation patterns. Hum Brain Mapp. doi:10.​1002/​hbm.​21345 PubMed
18.
Zurück zum Zitat Kriegeskorte N, Goebel R, Bandettini P (2006) Information-based functional brain mapping. Proc Natl Acad Sci USA 103:3863–3868PubMedCrossRef Kriegeskorte N, Goebel R, Bandettini P (2006) Information-based functional brain mapping. Proc Natl Acad Sci USA 103:3863–3868PubMedCrossRef
19.
Zurück zum Zitat Haynes JD, Sakai K, Rees G et al (2007) Reading hidden intentions in the human brain. Curr Biol 17:323–328PubMedCrossRef Haynes JD, Sakai K, Rees G et al (2007) Reading hidden intentions in the human brain. Curr Biol 17:323–328PubMedCrossRef
20.
Zurück zum Zitat Hardoon DR, Szedmak S, Shawe-Taylor J (2004) Canonical correlation analysis: an overview with application to learning methods. Neural Comput 16:2639–2664PubMedCrossRef Hardoon DR, Szedmak S, Shawe-Taylor J (2004) Canonical correlation analysis: an overview with application to learning methods. Neural Comput 16:2639–2664PubMedCrossRef
21.
Zurück zum Zitat Jolliffe IT (2002) Principal component analysis. Springer, Berlin Jolliffe IT (2002) Principal component analysis. Springer, Berlin
22.
Zurück zum Zitat Kriegeskorte N, Simmons WK, Bellgowan PS, Baker CI (2009) Circular analysis in systems neuroscience: the dangers of double dipping. Nat Neurosci 12:535–540PubMedCrossRef Kriegeskorte N, Simmons WK, Bellgowan PS, Baker CI (2009) Circular analysis in systems neuroscience: the dangers of double dipping. Nat Neurosci 12:535–540PubMedCrossRef
23.
Zurück zum Zitat Tzourio-Mazoyer N, Landeau B, Papthanassiou D et al (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15:273–289PubMedCrossRef Tzourio-Mazoyer N, Landeau B, Papthanassiou D et al (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15:273–289PubMedCrossRef
24.
Zurück zum Zitat Dehaene S, Molko N, Cohen L, Wilson AJ (2004) Arithmetic and the brain. Curr Opin Neurobiol 14:218–224PubMedCrossRef Dehaene S, Molko N, Cohen L, Wilson AJ (2004) Arithmetic and the brain. Curr Opin Neurobiol 14:218–224PubMedCrossRef
25.
Zurück zum Zitat Chard D, Miller D (2009) Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging. J Neurol Sci 282:5–11PubMedCrossRef Chard D, Miller D (2009) Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging. J Neurol Sci 282:5–11PubMedCrossRef
26.
Zurück zum Zitat Filippi M, Agosta F (2010) Imaging biomarkers in multiple sclerosis. [Review]. J Magn Reson Imaging 31:770–788PubMedCrossRef Filippi M, Agosta F (2010) Imaging biomarkers in multiple sclerosis. [Review]. J Magn Reson Imaging 31:770–788PubMedCrossRef
27.
Zurück zum Zitat Filippi M, Rocca MA, Colombo B et al (2002) Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. Neuroimage 15:559–567PubMedCrossRef Filippi M, Rocca MA, Colombo B et al (2002) Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. Neuroimage 15:559–567PubMedCrossRef
28.
Zurück zum Zitat Prinster A, Quarantelli M, Orefice G et al (2006) Grey matter loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study. Neuroimage 29:859–867PubMedCrossRef Prinster A, Quarantelli M, Orefice G et al (2006) Grey matter loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study. Neuroimage 29:859–867PubMedCrossRef
29.
Zurück zum Zitat Wylezinska M, Cifelli A, Jezzard P et al (2003) Thalamic neurodegeneration in relapsing-remitting multiple sclerosis. Neurology 60:1949–1954PubMedCrossRef Wylezinska M, Cifelli A, Jezzard P et al (2003) Thalamic neurodegeneration in relapsing-remitting multiple sclerosis. Neurology 60:1949–1954PubMedCrossRef
30.
Zurück zum Zitat Harirchian MH, Rezvanizadeh A, Fakhri M et al (2010) Non-invasive brain mapping of motor-related areas of four limbs in patients with clinically isolated syndrome compared to healthy normal controls. J Clin Neurosci 17:736–741PubMedCrossRef Harirchian MH, Rezvanizadeh A, Fakhri M et al (2010) Non-invasive brain mapping of motor-related areas of four limbs in patients with clinically isolated syndrome compared to healthy normal controls. J Clin Neurosci 17:736–741PubMedCrossRef
31.
Zurück zum Zitat Morgen K, Sammer G, Courtney SM et al (2007) Distinct mechanisms of altered brain activation in patients with multiple sclerosis. Neuroimage 37:937–946PubMedCrossRef Morgen K, Sammer G, Courtney SM et al (2007) Distinct mechanisms of altered brain activation in patients with multiple sclerosis. Neuroimage 37:937–946PubMedCrossRef
32.
Zurück zum Zitat Bodini B, Khaleeli Z, Cercignani M et al (2009) Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: an in vivo study with TBSS and VBM. Hum Brain Mapp 30:2852–2861PubMedCrossRef Bodini B, Khaleeli Z, Cercignani M et al (2009) Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: an in vivo study with TBSS and VBM. Hum Brain Mapp 30:2852–2861PubMedCrossRef
33.
Zurück zum Zitat Morgen K, Sammer G, Courtney SM et al (2006) Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS. Neuroimage 30:891–898PubMedCrossRef Morgen K, Sammer G, Courtney SM et al (2006) Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS. Neuroimage 30:891–898PubMedCrossRef
34.
Zurück zum Zitat Dineen RA, Vilisaar J, Hlinka J et al (2009) Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis. Brain 132:239–249PubMedCrossRef Dineen RA, Vilisaar J, Hlinka J et al (2009) Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis. Brain 132:239–249PubMedCrossRef
35.
Zurück zum Zitat Bakshi R, Benedict RH, Bermel RA, Jacobs L (2001) Regional brain atrophy is associated with physical disability in multiple sclerosis: semiquantitative magnetic resonance imaging and relationship to clinical findings. J Neuroimaging 11:129–136PubMedCrossRef Bakshi R, Benedict RH, Bermel RA, Jacobs L (2001) Regional brain atrophy is associated with physical disability in multiple sclerosis: semiquantitative magnetic resonance imaging and relationship to clinical findings. J Neuroimaging 11:129–136PubMedCrossRef
36.
Zurück zum Zitat Sailer M, Fischl B, Salat D et al (2003) Focal thinning of the cerebral cortex in multiple sclerosis. Brain 126:1734–1744PubMedCrossRef Sailer M, Fischl B, Salat D et al (2003) Focal thinning of the cerebral cortex in multiple sclerosis. Brain 126:1734–1744PubMedCrossRef
37.
Zurück zum Zitat Rudick RA, Lee JC, Nakamura K, Fisher E (2009) Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS. J Neurol Sci 282:106–111PubMedCrossRef Rudick RA, Lee JC, Nakamura K, Fisher E (2009) Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS. J Neurol Sci 282:106–111PubMedCrossRef
38.
Zurück zum Zitat Stevenson VL, Leary SM, Losseff NA et al (1998) Spinal cord atrophy and disability in MS: a longitudinal study. Neurology 51:234–238PubMedCrossRef Stevenson VL, Leary SM, Losseff NA et al (1998) Spinal cord atrophy and disability in MS: a longitudinal study. Neurology 51:234–238PubMedCrossRef
39.
Zurück zum Zitat Schmierer K, Parkes HG, So PW et al (2010) High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis. Brain 133:858–867PubMedCrossRef Schmierer K, Parkes HG, So PW et al (2010) High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis. Brain 133:858–867PubMedCrossRef
40.
Zurück zum Zitat Van Walderveen MA, Lycklama A, Nijeholt GJ et al (2001) Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis. Arch Neurol 58:76–81PubMedCrossRef Van Walderveen MA, Lycklama A, Nijeholt GJ et al (2001) Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis. Arch Neurol 58:76–81PubMedCrossRef
41.
Zurück zum Zitat Vrenken H, Geurts JJ, Knol DL et al (2006) Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter. Radiology 240:811–820PubMedCrossRef Vrenken H, Geurts JJ, Knol DL et al (2006) Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter. Radiology 240:811–820PubMedCrossRef
42.
Zurück zum Zitat Neema M, Stankiewicz J, Arora A et al (2007) T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis. J Neuroimaging 17(Suppl 1):16S–21SPubMedCrossRef Neema M, Stankiewicz J, Arora A et al (2007) T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis. J Neuroimaging 17(Suppl 1):16S–21SPubMedCrossRef
43.
Zurück zum Zitat Lucchinetti C, Brück W, Noseworthy J (2001) Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment. Curr Opin Neurol 14:259–269PubMedCrossRef Lucchinetti C, Brück W, Noseworthy J (2001) Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment. Curr Opin Neurol 14:259–269PubMedCrossRef
44.
Zurück zum Zitat Roosendaal SD, Geurts JJ, Vrenken H et al (2009) Regional DTI differences in multiple sclerosis patients. Neuroimage 44:1397–1403PubMedCrossRef Roosendaal SD, Geurts JJ, Vrenken H et al (2009) Regional DTI differences in multiple sclerosis patients. Neuroimage 44:1397–1403PubMedCrossRef
45.
Zurück zum Zitat Ge Y, Grossman RI, Babb JS et al (2003) Dirty-appearing white matter in multiple sclerosis: volumetric MR imaging and magnetization transfer ratio histogram analysis. Am J Neuroradiol 24:1935–1940PubMed Ge Y, Grossman RI, Babb JS et al (2003) Dirty-appearing white matter in multiple sclerosis: volumetric MR imaging and magnetization transfer ratio histogram analysis. Am J Neuroradiol 24:1935–1940PubMed
Metadaten
Titel
Can we overcome the ‘clinico-radiological paradox’ in multiple sclerosis?
verfasst von
Kerstin Hackmack
Martin Weygandt
Jens Wuerfel
Caspar F. Pfueller
Judith Bellmann-Strobl
Friedemann Paul
John-Dylan Haynes
Publikationsdatum
01.10.2012
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 10/2012
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-012-6475-9

Weitere Artikel der Ausgabe 10/2012

Journal of Neurology 10/2012 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.